{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:47:59Z","timestamp":1788893279829,"version":"build-2803163510"},"reference-count":39,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["#4183-00171B"],"award-info":[{"award-number":["#4183-00171B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To evaluate whether high glucose levels in the normoglycemic range and higher have a causal genetic effect on risk of retinopathy, neuropathy, nephropathy, chronic kidney disease (CKD), peripheral arterial disease (PAD), and myocardial infarction (MI; positive control) in the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>This study applied observational and one-sample Mendelian randomization (MR) analyses to individual-level data from 117,193 Danish individuals, and validation by two-sample MR analyses on summary-level data from 133,010 individuals from the Meta-Analyses of Glucose and Insulin-Related Traits Consortium (MAGIC), 117,165 from the CKDGen Consortium, and 452,264 from the UK Biobank.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Observationally, glucose levels in the normoglycemic range and higher were associated with high risks of retinopathy, neuropathy, diabetic nephropathy, PAD, and MI (all P for trend &amp;lt;0.001). In genetic causal analyses, the risk ratio for a 1 mmol\/L higher glucose level was 2.01 (95% CI 1.18\u20133.41) for retinopathy, 2.15 (1.38\u20133.35) for neuropathy, 1.58 (1.04\u20132.40) for diabetic nephropathy, 0.97 (0.84\u20131.12) for estimated glomerular filtration rate (eGFR) &amp;lt;60 mL\/min\/1.73 m2, 1.19 (0.90\u20131.58) for PAD, and 1.49 (1.02\u20132.17) for MI. Summary-level data from the MAGIC, the CKDGen Consortium, and the UK Biobank gave a genetic risk ratio of 4.55 (95% CI 2.26\u20139.15) for retinopathy, 1.48 (0.83\u20132.66) for peripheral neuropathy, 0.98 (0.94\u20131.01) for eGFR &amp;lt;60 mL\/min\/1.73 m2, and 1.23 (0.57\u20132.67) for PAD per 1 mmol\/L higher glucose level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Glucose levels in the normoglycemic range and higher were prospectively associated with a high risk of retinopathy, neuropathy, diabetic nephropathy, eGFR &amp;lt;60 mL\/min\/1.73 m2, PAD, and MI. These associations were confirmed in genetic causal analyses for retinopathy, neuropathy, diabetic nephropathy, and MI, but they could not be confirmed for PAD and seemed to be refuted for eGFR &amp;lt;60 mL\/min\/1.73 m2.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc19-1850","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T17:54:20Z","timestamp":1581616460000},"page":"894-902","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":45,"title":["Impact of Glucose Level on Micro- and Macrovascular Disease in the General Population: A Mendelian Randomization Study"],"prefix":"10.2337","volume":"43","author":[{"given":"Frida","family":"Emanuelsson","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Marott","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybj\u00e6rg-Hansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark"},{"name":"The Copenhagen City Heart Study, Frederiksberg and Bispebjerg Hospital, Copenhagen University Hospital, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-7220","authenticated-orcid":false,"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark"},{"name":"The Copenhagen City Heart Study, Frederiksberg and Bispebjerg Hospital, Copenhagen University Hospital, Frederiksberg, Denmark"},{"name":"Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1701-595X","authenticated-orcid":false,"given":"Marianne","family":"Benn","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"2022031223520451700_B1","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2012.02.043","article-title":"Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study","volume":"59","author":"Benn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022031223520451700_B2","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"2022031223520451700_B3","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2337\/dc06-0942","article-title":"The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey","volume":"29","author":"Bonadonna","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031223520451700_B4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031223520451700_B5","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"key":"2022031223520451700_B6","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dbi17-0044","article-title":"Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences","volume":"67","author":"Stehouwer","year":"2018","journal-title":"Diabetes"},{"key":"2022031223520451700_B7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12982-015-0037-4","article-title":"Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology","volume":"12","author":"Fedak","year":"2015","journal-title":"Emerg Themes Epidemiol"},{"key":"2022031223520451700_B8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"2022031223520451700_B9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa062418","article-title":"TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program","volume":"355","author":"Florez","year":"2006","journal-title":"N Engl J Med"},{"key":"2022031223520451700_B10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00125-010-2038-8","article-title":"Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B","volume":"54","author":"Hribal","year":"2011","journal-title":"Diabetologia"},{"key":"2022031223520451700_B11","unstructured":"UK Biobank\n          . UK Biobank: protocol for a large-scale prospective epidemiological resource\u2008[Internet], 21 March 2007. Available from www.ukbiobank.ac.uk\/wp-content\/uploads\/2011\/11\/UK-Biobank-Protocol.pdf. Accessed 9 February 2020"},{"key":"2022031223520451700_B12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41588-018-0248-z","article-title":"An atlas of genetic associations in UK Biobank","volume":"50","author":"Canela-Xandri","year":"2018","journal-title":"Nat Genet"},{"key":"2022031223520451700_B13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.2385","article-title":"Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways","volume":"44","author":"Scott","year":"2012","journal-title":"Nat Genet"},{"key":"2022031223520451700_B14","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1038\/ncomms10023","article-title":"Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function","volume":"7","author":"Pattaro","year":"2016","journal-title":"Nat Commun"},{"key":"2022031223520451700_B15","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes\u20142018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031223520451700_B16","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/ije\/dyt093","article-title":"Use of allele scores as instrumental variables for Mendelian randomization","volume":"42","author":"Burgess","year":"2013","journal-title":"Int J Epidemiol"},{"key":"2022031223520451700_B17","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"2022031223520451700_B18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022031223520451700_B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536867X0300300101","article-title":"Instrumental variables and GMM: estimation and testing","volume":"3","author":"Baum","year":"2003","journal-title":"Stata J"},{"key":"2022031223520451700_B20","author":"Nichols"},{"key":"2022031223520451700_B21","first-page":"1192","article-title":"From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment","volume":"114","author":"Benn","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2022031223520451700_B22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2022031223520451700_B23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MCO.0000000000000307","article-title":"Prediabetes and risk of diabetes and associated complications: impaired fasting glucose versus impaired glucose tolerance: does it matter","volume":"19","author":"Abdul-Ghani","year":"2016","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2022031223520451700_B24","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.116.023446","article-title":"Prediabetes and type 2 diabetes are associated with generalized microvascular dysfunction: the Maastricht Study","volume":"134","author":"S\u00f6rensen","year":"2016","journal-title":"Circulation"},{"key":"2022031223520451700_B25","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2337\/dc14-2733","article-title":"Corneal confocal microscopy identifies small-fiber neuropathy in subjects with impaired glucose tolerance who develop type 2 diabetes","volume":"38","author":"Azmi","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031223520451700_B26","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.2337\/dc14-0817","article-title":"We can change the natural history of type 2 diabetes","volume":"37","author":"Phillips","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031223520451700_B27","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"key":"2022031223520451700_B28","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","article-title":"Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study","volume":"368","author":"Lindstr\u00f6m","year":"2006","journal-title":"Lancet"},{"key":"2022031223520451700_B29","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","article-title":"The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study","volume":"371","author":"Li","year":"2008","journal-title":"Lancet"},{"key":"2022031223520451700_B30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study","volume":"7","author":"Gong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031223520451700_B31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","article-title":"CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease","volume":"14","author":"Anders","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2022031223520451700_B32","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"2022031223520451700_B33","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","article-title":"Molecular and cellular mechanisms of cardiovascular disorders in diabetes","volume":"118","author":"Shah","year":"2016","journal-title":"Circ Res"},{"key":"2022031223520451700_B34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MOL.0b013e328348a43f","article-title":"Susceptibility of LDL and its subfractions to glycation","volume":"22","author":"Soran","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"2022031223520451700_B35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2337\/db10-0839","article-title":"Association of a fasting glucose genetic risk score with subclinical atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study","volume":"60","author":"Rasmussen-Torvik","year":"2011","journal-title":"Diabetes"},{"key":"2022031223520451700_B36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ije\/dyx206","article-title":"Collider scope: when selection bias can substantially influence observed associations","volume":"47","author":"Munaf\u00f2","year":"2018","journal-title":"Int J Epidemiol"},{"key":"2022031223520451700_B37","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"2022031223520451700_B38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2022031223520451700_B39","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc19-1850","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/4\/894\/532544\/dc191850.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/4\/894\/532544\/dc191850.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T21:48:44Z","timestamp":1647121724000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/4\/894\/35826\/Impact-of-Glucose-Level-on-Micro-and-Macrovascular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,2,13]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc19-1850","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]}}}